In 2014, I started with the Bachelor’s program of Life Science and Technology at the University of Groningen with a specialization in medical pharmaceutical sciences and an exchange program at the University of Umeå (Sweden). During my internship at the Department of Clinical Pharmacy and Pharmacology (University Medical Center Groningen), I investigated the molecular mechanism of several compounds on the α1-adrenergic receptor which triggered my interest in molecular pharmacology research. Therefore, I continued with the Bio-Pharmaceutical Sciences Master at Leiden University. For my first internship at the Division of Drug Discovery and Safety, I investigated structure-affinity and structure-kinetic relationships of the hENT1. Thereafter, I performed my second internship at the Leiden University Medical Center where I histologically analyzed and compared stem cell-derived xenografts and human germ cell tumors. Simultaneously, I took part in the Leiden Leadership Programme during which I also carried out a project at Zorg & Zekerheid. In 2019, I started my PhD at the Division of Drug Discovery and Safety under supervision of prof. dr. L.H. Heitman and prof. dr. M. van der Stelt. I will focus on gaining new insights into targeting the cannabinoid receptor 2 (CB2) from a molecular pharmacological approach.
No relevant ancillary activities